SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442198
Filing Date
2013-11-14
Accepted
2013-11-14 16:31:24
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d598248d10q.htm 10-Q 190548
2 CERTIFICATION d598248dex311.htm EX-31.1 6024
3 CERTIFICATION d598248dex312.htm EX-31.2 6027
4 CERTIFICATION d598248dex321.htm EX-32.1 2745
5 CERTIFICATION d598248dex322.htm EX-32.2 2747
  Complete submission text file 0001193125-13-442198.txt   1830406

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hppi-20130930.xml EX-101.INS 140427
7 XBRL TAXONOMY EXTENSION SCHEMA hppi-20130930.xsd EX-101.SCH 30510
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20130930_cal.xml EX-101.CAL 26636
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20130930_def.xml EX-101.DEF 92032
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20130930_lab.xml EX-101.LAB 213089
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20130930_pre.xml EX-101.PRE 137160
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 131220651
SIC: 8731 Services-Commercial Physical & Biological Research